Recursion Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.79-$12.36 |
Market Cap | $2.1B |
Shares Short | 124M |
Financials
See moreRevenue (12 Mos) | $64.5M |
Revenue Growth (YoY) | 33.3% |
Gross Profit (12 Mos) | -$433.4M |
Diluted EPS | -$1.81 |
News
See moreYahoo Finance • 10 days ago
Needham Retains Buy Rating on Recursion Pharmaceuticals, Maintains PT at $8
Yahoo Finance • 22 days ago
When You Buy Nvidia Stock, You Get a Bonus: An Artificial Intelligence (AI) ETF of Sorts
Yahoo Finance • last month
Recursion Pharmaceuticals (RXRX) Drops on 3rd Day as Company Execs Dispose of Shares
Yahoo Finance • last month
Recursion pharma director Khan sells $202k in shares
About
CEO | Dr. Christopher C. Gibson Ph.D. |
CFO | Mr. Ben R. Taylor |
Address | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 800 |
